Sanofi Logo

Sanofi Disease Education

Sanofi Disease Education

Sanofi is committed to educating patients and healthcare professionals about diseases and conditions. This section provides information about specific cancer types and complications from cancer treatment for which there are unmet therapeutic needs and emerging information.

Learn more about:


1. Virág L, Szabó C. Pharmacol Rev. 2002;54(3):375-429. 2. Bryant HE, Helleday T. Inhibition of poly(ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res. 2006;34(6):1685-1691. 3. Ashworth A. J Clin Oncol. 2008;26(22):3785-3790. 4. Bryant HE, Helleday T. Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents. Biochem Soc Trans. 2004;32(Pt6):959-961.

Sanofi joins the fight against prostate cancer

ON THE LINE is a prostate cancer awareness campaign and Sanofi is co-sponsoring this initiative to help educate men and women about the importance of prostate screening. The campaign focuses on health education that harnesses the power of sports and celebrities to challenge men to take charge of their health. ON THE LINE offers educational materials for both men and women on prostate cancer, to promote a true "team" approach.

And Sanofi is fighting prostate cancer every way we can too. We know the stakes. Prostate cancer is the most commonly diagnose cancer in American men today. Every five minutes two more men are diagnosed with the disease. And it's the second leading cause of cancer death in the U.S.

From our earliest days, the goals of our cancer research have remained steadfast: to battle cancer with the most effective agents we can develop, to reduce the side effects of chemotherapy and to create breakthrough therapies for cancer patients. With the availability of new research techniques, we are also investigating targeted agents and novel approaches that may one day play an important role in advancing cancer management.

For more information about ON THE LINE, visit

Share the fight against prostate cancer.
Visit ON THE LINE on Facebook and YouTube

[Top of Page]